Recent work has shown that blocking pro-inflammatory cytokines, including TNFα, IL-1β, and IL-6, can reduce the permeability of BBB and improve the outcomes of neurological diseases and injuries to a great extent. The gene discussed is IL6; the disease is nervous system disorder.